GE introduces tumor visualization technology at ESTRO

GE Healthcare showcased its new tumor visualization and radiation therapy planning technology last week at the European Society for Therapeutic Radiology and Oncology (ESTRO) 29th annual meeting in Barcelona, Spain.

The company introduced new CT systems: Discovery CT590 RT and Optima CT580. Discovery provides soft tissue visualization and reduces image noise and contrast resolution via adaptive statistical iterative reconstruction for lesion contouring and targeting, and the wide-bore Optima, designed for radiotherapy simulation, can be integrated with treatment planning systems and provides the image quality needed for intensity modulated radiation therapy and conformal therapy, GE stated. 

In addition to CT systems, GE also showcased its MR scanner for radiation therapy planning, the Optima MR450w. According to the company, the technology can facilitate tumor targeting in the neck, head and pelvis and offers more accurate patient positioning.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.